W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

News

03 November, 2025
Announcement by the President of AOTMiT on the current threshold for the cost of obtaining an additional year of life adjusted for quality
read more
03 November, 2025
Recommendation of the President regarding #HPP #48aa – Prevention of cerebrovascular diseases, including stroke
read more
03 November, 2025
Recommendation of the President regarding #HPP #48aa – Prevention and early detection of rheumatoid arthritis
read more
03 November, 2025
Recommendation of the President regarding #HPP #48aa – Prevention of chronic back pain
read more
03 November, 2025
Recommendation of the President – Ospolot (sultiam)
read more
03 November, 2025
Recommendation of the President – Aquipta
read more
03 November, 2025
Recommendation of the President – optometrist consultations
read more
31 October, 2025
Publication AWA
read more
30 October, 2025
Recommendation of the President – K.Vita
read more
28 October, 2025
Communication of the meeting of Tariff Council on 9 October 2025
read more
28 October, 2025
Recommendation of the President – Evrysdi (risdiplam)
read more
24 October, 2025
Publication AWA
read more
24 October, 2025
Status of work in October
read more
23 October, 2025
Opinion of the President – Health policy program for the prevention of infectious diseases in the municipality of Nowiny for the years 2026-2030
read more
23 October, 2025
Opinion of the President – Health Policy Program for the medical rehabilitation of residents of the Malczyce Municipality for the years 2026-2029
read more
23 October, 2025
Opinion of the President – Prevention of musculoskeletal disorders through rehabilitation for children, young people, working adults, and seniors
read more
23 October, 2025
Opinion of the President – Find your balance – a program of emotional support and prevention of depressive disorders among young people from schools in the Żarski County for the years 2026-2027
read more
23 October, 2025
Opinion of the President – Health policy program for screening for hearing and vision defects in children living in the Mazowieckie Province
read more
22 October, 2025
Recommendation of the President – Pemazyre (pemigatinib)
read more
22 October, 2025
Recommendation of the President – standard vestibular plates
read more
22 October, 2025
Recommendation of the President – Tevimbra (tislelizumab)
read more
22 October, 2025
Recommendation of the President – Tevimbra (tislelizumab)
read more
22 October, 2025
Recommendation of the President regarding #HPP #48aa – Prevention of skin cancer
read more
22 October, 2025
Recommendation of the President regarding #HPP #48aa – Prevention of chronic obstructive pulmonary disease
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑

Telefon

Page header

News

Announcement by the President of AOTMiT on the current threshold for the cost of obtaining an additional year of life adjusted for quality

Recommendation of the President regarding #HPP #48aa – Prevention of cerebrovascular diseases, including stroke

Recommendation of the President regarding #HPP #48aa – Prevention and early detection of rheumatoid arthritis

Recommendation of the President regarding #HPP #48aa – Prevention of chronic back pain

Recommendation of the President – Ospolot (sultiam)

Recommendation of the President – Aquipta

Recommendation of the President – optometrist consultations

Publication AWA

Recommendation of the President – K.Vita

Communication of the meeting of Tariff Council on 9 October 2025

Recommendation of the President – Evrysdi (risdiplam)

Publication AWA

Status of work in October

Opinion of the President – Health policy program for the prevention of infectious diseases in the municipality of Nowiny for the years 2026-2030

Opinion of the President – Health Policy Program for the medical rehabilitation of residents of the Malczyce Municipality for the years 2026-2029

Opinion of the President – Prevention of musculoskeletal disorders through rehabilitation for children, young people, working adults, and seniors

Opinion of the President – Find your balance – a program of emotional support and prevention of depressive disorders among young people from schools in the Żarski County for the years 2026-2027

Opinion of the President – Health policy program for screening for hearing and vision defects in children living in the Mazowieckie Province

Recommendation of the President – Pemazyre (pemigatinib)

Recommendation of the President – standard vestibular plates

Recommendation of the President – Tevimbra (tislelizumab)

Recommendation of the President – Tevimbra (tislelizumab)

Recommendation of the President regarding #HPP #48aa – Prevention of skin cancer

Recommendation of the President regarding #HPP #48aa – Prevention of chronic obstructive pulmonary disease